Search research articles
Contact Us
Filters
Showing results (131-140 of 267) with videos related to
Page
of 27
Sort By:
Hepatology (Baltimore, Md.)
|
January 25, 2022
Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgery
Raluca Pais, Judith Aron-Wisnewsky, Pierre Bedossa, et al.
Journal of the Endocrine Society
|
January 1, 2026
Improving MASLD Risk Stratification in Young Adults with Cardiometabolic Risk Factors and Insulin Resistance Assessment
Anu Sharma, Eddison Godinez Leiva, Srilaxmi Kalavalapalli, et al.
Plos One
|
June 16, 2016
Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon
Roberta D'Ambrosio, Elisabetta Degasperi, Alessio Aghemo, et al.
European Journal of Gastroenterology & Hepatology
|
November 19, 2020
Microcirculatory changes in the liver of patients with refractory ascites and their relationship with diabetes and alcohol
Laure Elkrief, Sophie Buyse, Xavière Panhard, et al.
Biomedicines
|
March 25, 2022
Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19
Olivier Deckmyn, Thierry Poynard, Pierre Bedossa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 30, 2018
Persistence of hepatocellular carcinoma risk in hepatitis C patients with a response to IFN and cirrhosis regression
Roberta D'Ambrosio, Alessio Aghemo, Maria Grazia Rumi, et al.
Oncotarget
|
February 23, 2018
<i>In vitro</i>, <i>in vivo</i> and <i>ex vivo</i> demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma
Stéphanie Dayot, Daniela Speisky, Anne Couvelard, et al.
Contemporary Clinical Trials
|
July 2, 2019
REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis
Vlad Ratziu, Arun J Sanyal, Rohit Loomba, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
March 22, 2014
In situ proteomic analysis by MALDI imaging identifies ubiquitin and thymosin-β4 as markers of malignant intraductal pancreatic mucinous neoplasms
Vinciane Rebours, Julie Le Faouder, Samira Laouirem, et al.
Urology
|
May 20, 2008
Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer
Eva Compérat, Ivan Bièche, Delphine Dargère, et al.
Page
of 27
Search research articles
Search
Showing results (131-140 of 267) with videos related to
Sort By:
Page
of 27
Hepatology (Baltimore, Md.)
|
January 25, 2022
Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgery
Raluca Pais, Judith Aron-Wisnewsky, Pierre Bedossa, et al.
Journal of the Endocrine Society
|
January 1, 2026
Improving MASLD Risk Stratification in Young Adults with Cardiometabolic Risk Factors and Insulin Resistance Assessment
Anu Sharma, Eddison Godinez Leiva, Srilaxmi Kalavalapalli, et al.
Plos One
|
June 16, 2016
Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon
Roberta D'Ambrosio, Elisabetta Degasperi, Alessio Aghemo, et al.
European Journal of Gastroenterology & Hepatology
|
November 19, 2020
Microcirculatory changes in the liver of patients with refractory ascites and their relationship with diabetes and alcohol
Laure Elkrief, Sophie Buyse, Xavière Panhard, et al.
Biomedicines
|
March 25, 2022
Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19
Olivier Deckmyn, Thierry Poynard, Pierre Bedossa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 30, 2018
Persistence of hepatocellular carcinoma risk in hepatitis C patients with a response to IFN and cirrhosis regression
Roberta D'Ambrosio, Alessio Aghemo, Maria Grazia Rumi, et al.
Oncotarget
|
February 23, 2018
<i>In vitro</i>, <i>in vivo</i> and <i>ex vivo</i> demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma
Stéphanie Dayot, Daniela Speisky, Anne Couvelard, et al.
Contemporary Clinical Trials
|
July 2, 2019
REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis
Vlad Ratziu, Arun J Sanyal, Rohit Loomba, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
March 22, 2014
In situ proteomic analysis by MALDI imaging identifies ubiquitin and thymosin-β4 as markers of malignant intraductal pancreatic mucinous neoplasms
Vinciane Rebours, Julie Le Faouder, Samira Laouirem, et al.
Urology
|
May 20, 2008
Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer
Eva Compérat, Ivan Bièche, Delphine Dargère, et al.
Page
of 27